Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Edelman

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Family Practice|August 7, 2023
Early Intervention by Family Physicians to Delay Type 1 DiabetesSteven Edelman
The American Journal of Medicine|October 6, 2014
Challenges associated with insulin therapy in type 2 diabetes mellitusSteven Edelman, Jeremy Pettus
Core Evidence|November 3, 2010
Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitusKristen Kulasa, Steven Edelman
Postgraduate Medicine|June 12, 2014
Biosimilar insulins are coming: the top 10 things you should knowIan Blumer, Steven Edelman
Diabetes, Obesity & Metabolism|March 23, 2023
Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challengesPreethika Ekanayake, Steven Edelman
Clinical Therapeutics|July 22, 2014
Inhaled insulin: a breath of fresh air? A review of inhaled insulinTricia Santos Cavaiola, Steven Edelman
Journal of Diabetes Science and Technology|February 18, 2016
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of DiabetesDavid Ahn, Jeremy Pettus, Steven Edelman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2018
A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULINRichard Dolinar, Frank Lavernia, Steven Edelman
Clinical Immunology (Orlando, Fla.)|May 7, 2013
GLP-1 agonists in type 1 diabetesJeremy Pettus, Irl Hirsch, Steven Edelman
Current Medical Research and Opinion|August 9, 2014
Biosimilar insulins are coming: what they are, what you need to knowSteven Edelman, William H Polonsky, Christopher G Parkin
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Family Practice|August 7, 2023
Early Intervention by Family Physicians to Delay Type 1 DiabetesSteven Edelman
The American Journal of Medicine|October 6, 2014
Challenges associated with insulin therapy in type 2 diabetes mellitusSteven Edelman, Jeremy Pettus
Core Evidence|November 3, 2010
Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitusKristen Kulasa, Steven Edelman
Postgraduate Medicine|June 12, 2014
Biosimilar insulins are coming: the top 10 things you should knowIan Blumer, Steven Edelman
Diabetes, Obesity & Metabolism|March 23, 2023
Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challengesPreethika Ekanayake, Steven Edelman
Clinical Therapeutics|July 22, 2014
Inhaled insulin: a breath of fresh air? A review of inhaled insulinTricia Santos Cavaiola, Steven Edelman
Journal of Diabetes Science and Technology|February 18, 2016
Unblinded CGM Should Replace Blinded CGM in the Clinical Management of DiabetesDavid Ahn, Jeremy Pettus, Steven Edelman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2018
A GUIDE TO FOLLOW-ON BIOLOGICS AND BIOSIMILARS WITH A FOCUS ON INSULINRichard Dolinar, Frank Lavernia, Steven Edelman
Clinical Immunology (Orlando, Fla.)|May 7, 2013
GLP-1 agonists in type 1 diabetesJeremy Pettus, Irl Hirsch, Steven Edelman
Current Medical Research and Opinion|August 9, 2014
Biosimilar insulins are coming: what they are, what you need to knowSteven Edelman, William H Polonsky, Christopher G Parkin
Pageof 3